Group 1 - The company, Beijing Zhaoyan New Drug Research Center Co., Ltd., has approved an investment of up to 20 million RMB to participate in the establishment of the Huaxia Zhiyuan Venture Capital Fund [1][2] - The fund is managed by Huaxia Equity Investment Fund Management (Beijing) Co., Ltd., which serves as the general partner and fund manager [1] - The fund has completed the private investment fund registration with the Asset Management Association of China and obtained the Private Investment Fund Registration Certificate on August 27, 2025 [3] Group 2 - The fund's name is Huaxia Zhiyuan Venture Capital Fund (Beijing) Partnership (Limited Partnership) [3] - The custodian of the fund is Ping An Bank Co., Ltd. [3] - The registration code for the fund is SASP05 [3]